Trial Details

Authorised
Basic Information
Clinical ID c5127
Identifier EUCTR2009-018034-11-SE
Trial Title Open pilot study of treatment with vancomycin to children and adolescents with primary sclerosing cholangitis - vanco-psc
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Primary Sclerosing Cholangitis (PSC) is a progressive disease of the biliary system which might lead to increased risk of cholangiocancer. PSC constitutes a common indication for adult liver transplantation (ltx). In 80% of cases PSC is associated with in
Interventions Trade Name: VancomycinProduct Name: vancomycinPharmaceutical Form: CapsuleTrade Name: vancomycinProduct Name: VancomycinPharmaceutical Form: Oral solution
Participant Information
Sponsor Karolinska Institutet
City NULL
Country/Region Sweden
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL